![]() |
市場調查報告書
商品編碼
2144380
後生元食品配料市場預測至2034年-按配料類型、微生物來源、功能功效、應用、形態和地區分類的全球分析Postbiotic Food Ingredients Market Forecasts to 2034 - Global Analysis By Ingredient Type, Microbial Source, Functional Benefit, Application, Form, and Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球後生元食品配料市場將達到 5 億美元,並在預測期內以 20.0% 的複合年成長率成長,到 2034 年達到 21.5 億美元。
後生元食品配料是指含有去活化微生物、微生物成分或微生物發酵代謝物的配方,這些成分被添加到食品和飲料中以達到功能性或營養性目的。與益生菌不同,後生元配料無需活微生物即可在產品的整個保存期限或食用期內存活。它們可以添加到機能飲料、乳製品、營養食品、膳食補充劑和其他配方中。其潛在優勢在於提高了配方的穩定性和相容性,即使在可能影響活微生物的加工和儲存條件下,也能保持穩定。人們對微生物組科學日益成長的興趣正在推動後生元配料的研究和商業化。製造商正在探索其在消化器官系統、免疫系統和整體健康方面的應用。發酵技術、微生物表徵、穩定化技術和配料加工技術的進步正在拓展後生元食品配方的應用前景。
市場動態
消費者對腸道健康和免疫力的需求日益成長
消費者對腸道健康和免疫支持的需求日益成長,推動了後生元食品配料的普及。人們對後生元在健康方面作用的認知不斷提高,也促進了市場擴張。後生元及其功效研究的進展推動了產品開發。消化器官系統和免疫系統健康問題的日益普遍,加速了產品的推廣應用。後生元正逐漸成為關鍵的功能性成分。
認知度低和監理挑戰
消費者對後生元功效的認知度較低以及監管方面的挑戰是限制市場成長的障礙。後生元的法律規範因地區而異。後生元強化產品的高定價可能會限制其在大眾市場的吸引力。配方方面的技術挑戰正在影響產品開發。消費者對後生元功效的懷疑態度可能會阻礙其普及。
後生元原料配方創新
後生元原料和配方的創新帶來了巨大的成長機會。穩定性和功能性增強的後生元的開發正在拓展其應用範圍。臨床研究後生元的日益普及正在增強消費者的信心。與食品飲料生產商的合作正在加速產品開發。技術進步不斷提升後生元的功能性。
與益生菌和益生元的競爭
益生菌和益生元的競爭可能會限制後生元成分的普及。經濟壓力可能會影響食品生產商對添加後生元的投資。影響後生元功效聲明的監管變化可能會對行銷產生負面影響。消費者對後生元功效的懷疑可能會影響其普及化。成熟品類的市場飽和可能會限制其成長。
新冠感染疾病加劇了人們對腸道健康和免疫力的關注,加速了對後生元食品原料的需求。消費者對腸道與免疫力之間關聯的認知不斷提高,推動了市場擴張。即使在疫情後時期,人們對後生元產品的興趣依然持續。疫情封鎖期間,電商通路促進了產品的供應。人們對預防醫學日益成長的興趣也促進了產品的普及。
在預測期內,去活化益生菌細胞細分市場預計將佔據最大佔有率。
預計在預測期內,去活化益生菌細胞將佔據最大的市場佔有率。這是因為與活性益生菌相比,去活化益生菌細胞具有更優異的穩定性和安全性。消費者對高穩定性、保存期限長的產品的需求不斷成長,推動了市場擴張。對去活化細胞的深入研究鞏固了該細分市場的領先地位。去活化益生菌細胞是應用最廣泛的後生元成分。
預計在預測期內,雙歧桿菌細分市場將呈現最高的複合年成長率。
在預測期內,雙歧桿菌細分市場預計將呈現最高的成長率,這主要得益於對雙歧桿菌來源的後生元及其健康益處的研究不斷深入。消費者對免疫和腸道健康產品的需求不斷成長,也推動了市場擴張。生產技術的進步提高了成本競爭力。雙歧桿菌來源的後生元正逐漸成為關鍵成分。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於消費者對腸道健康產品的高需求、後生元原料公司的強大實力以及發達的食品工業。美國擁有許多後生元原料公司,並具備成熟的生產能力。較高的可支配收入和日益增強的健康意識正在鞏固其在該地區市場的領先地位。對含後生元產品的需求不斷成長,正在推動全部區域這類產品的廣泛應用。
在預測期內,歐洲預計將呈現最高的複合年成長率,這主要得益於強力的腸道健康標籤監管支持、消費者對後生元認知度的提高以及對機能性食品需求的成長。歐盟政策正在支持後生元食品的發展。大量的研究經費和企業投資為技術進步提供了支撐。強烈的健康意識正在推動全部區域後生元成分的採用。
According to Stratistics MRC, the Global Postbiotic Food Ingredients Market is accounted for $0.5 billion in 2026 and is expected to reach $2.15 billion by 2034 growing at a CAGR of 20.0% during the forecast period. Postbiotic Food Ingredients comprise preparations containing inactivated microorganisms, microbial components, or metabolites produced through microbial fermentation that are incorporated into foods and beverages for functional or nutritional purposes. Unlike probiotics, postbiotic ingredients do not require live microorganisms to remain viable throughout product storage and consumption. They can be incorporated into functional beverages, dairy products, nutritional foods, supplements, and other formulations. Their potential advantages include improved formulation stability and compatibility with products exposed to processing or storage conditions that may affect live cultures. Growing interest in microbiome science is supporting research and commercialization of postbiotic ingredients. Manufacturers are exploring applications related to digestive, immune, and general wellness. Advances in fermentation, microbial characterization, stabilization, and ingredient processing are expanding opportunities for postbiotic food formulations.
Market Dynamics
Growing consumer demand for gut health and immunity
Increasing consumer demand for gut health and immune support is driving adoption of postbiotic food ingredients. Growing awareness of the role of postbiotics in health supports market expansion. Advances in research on postbiotics and their benefits drive product development. Rising prevalence of digestive and immune health issues accelerates product adoption. Postbiotics are emerging as key functional ingredients.
Limited awareness and regulatory challenges
Limited consumer awareness of postbiotic benefits and regulatory challenges present barriers to market growth. Regulatory frameworks for postbiotics vary significantly across regions. Price premiums for postbiotic-fortified products may limit mass-market appeal. Technical challenges in formulation affect product development. Consumer skepticism regarding postbiotic benefits may affect adoption.
Innovation in postbiotic ingredients and formulations
Innovation in postbiotic ingredients and formulations presents significant growth opportunities. Development of postbiotics with improved stability and functionality is expanding applications. Growing availability of clinically studied postbiotics is building consumer confidence. Partnerships with food and beverage manufacturers accelerate product development. Technology advances continue improving postbiotic functionality.
Competition from probiotics and prebiotics
Competition from probiotics and prebiotics may limit adoption of postbiotic ingredients. Economic pressures may affect food manufacturers' investment in postbiotic fortification. Regulatory changes affecting postbiotic claims may impact marketing. Consumer skepticism regarding postbiotic benefits may affect adoption. Market saturation in mature categories may constrain growth.
The COVID-19 pandemic increased focus on gut health and immunity, accelerating demand for postbiotic food ingredients. Growing consumer awareness of the gut-immune connection supports market expansion. The post-pandemic period has witnessed sustained interest in postbiotic products. E-commerce channels facilitated product access during lockdowns. Growing focus on preventive health drives product adoption.
The inactivated probiotic cells segment is expected to be the largest during the forecast period
The inactivated probiotic cells segment is expected to account for the largest market share during the forecast period as inactivated probiotic cells offer stability and safety advantages over live probiotics. Growing consumer demand for stable, shelf-stable products drives market expansion. Established research on inactivated cells supports segment leadership. Inactivated probiotic cells are the most widely used postbiotic ingredient.
The Bifidobacterium segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Bifidobacterium segment is predicted to witness the highest growth rate driven by increasing research on Bifidobacterium-derived postbiotics and their health benefits. Growing consumer demand for immune and gut health products supports market expansion. Advances in production technology improve cost competitiveness. Bifidobacterium postbiotics are emerging as key ingredients.
During the forecast period, the North America region is expected to hold the largest market share owing to high consumer demand for gut health products, strong presence of postbiotic ingredient companies, and advanced food industry. The United States hosts major postbiotic ingredient companies with established production capabilities. High disposable incomes and health consciousness reinforce regional market leadership. Growing demand for postbiotic-fortified products drives adoption across the region.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by strong regulatory support for gut health claims, growing consumer awareness of postbiotics, and increasing demand for functional foods. European Union policies support postbiotic food development. Significant research funding and corporate investment support technology development. Strong health culture drives adoption of postbiotic ingredients across the region.
Key players in the market
Some of the key players in the Postbiotic Food Ingredients Market include ADM, DSM-Firmenich AG, Novonesis A/S, Kerry Group plc, Ingredion Incorporated, Chr. Hansen Holding A/S, Lallemand Inc., Kaneka Corporation, AB-BIOTICS S.A., Paragon Laboratories, SAB Biotherapeutics, Probi AB, OptiBiotix Health plc, Lesaffre, and Postbiotics Plus.
In May 2025, ADM launched a new generation of postbiotic ingredients with enhanced stability and functionality for gut health applications. The ingredients offer improved shelf-life and efficacy. The development responds to growing demand for postbiotic solutions.
In April 2025, DSM-Firmenich AG announced significant expansion of its postbiotic ingredient portfolio with new products for immune and metabolic health.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.